\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ examination\\ reveals\\ positive\\ lhermitte\\ sign\\ \\(lhermitte\\ sign\\ is\\ an\\ electric\\ shock\\-like\\ sensation\\ that\\ occurs\\ when\\ flexing\\ or\\ moving\\ the\\ neck\\.\\ this\\ sensation\\ radiates\\ down\\ the\\ spine\\,\\ often\\ into\\ the\\ legs\\,\\ arms\\,\\ and\\ occasionally\\,\\ the\\ trunk\\.\\)\ \(0\)\
\-\ the\\ patient\\ also\\ underwent\\ a\\ c\\-spine\\ and\\ th\\-spine\\ mri\\ scan\\ which\\ have\\ not\\ revealed\\ any\\ new\\ or\\ active\\ ms\\ lesions\\.\\ \\ \\ the\\ patient\\ is\\ in\\ good\\ clinical\\ condition\\ without\\ any\\ significant\\ motor\\ or\\ sensory\\ deficits\\.\ \(0\)\
\-\ in\\ the\\ light\\ of\\ the\\ new\\ imaging\\ and\\ clinical\\ findings\\ \\,\\ \\ the\\ patient\\ is\\ placed\\ on\\ a\\ different\\ \\ therapy\\.\ \(0\)\
\-\ multiplanar\\ mr\\ imaging\\ demonstrates\\ the\\ presence\\ of\\ two\\ new\\ demyelinating\\ lesions\\ in\\ juxtacortical\\ white\\ matter\\ of\\ the\\ left\\ frontal\\ lobe\\ compared\\ with\\ a\\ previous\\ brain\\ mri\\ scan\\ performed\\ three\\ months\\ ago\\.\\ these\\ new\\ lesions\\ enhance\\ vividly\\ after\\ gadolinium\\ \\-based\\ contrast\\ administration\\,\\ indicating\\ active\\ disease\\.\ \(0\)\
\-\ multiple\\ sclerosis\\-\\ active\\ stage\\.\ \(0\)\
\-\ differential\\ diagnosis\\ includes\\:\\ adem\\ \\,sarcoid\\,\\ vasculitis\\,\\ ischemic\\-hypoxic\\ lesions\\,\\ \\ susac\\ syndrome\\.\ \(0\)\
\-\ tumefactive\\ multiple\\ sclerosis\\ must\\ be\\ differentiated\\ from\\ neoplasm\\.\ \(0\)\
\-\ a\\ 35\\-year\\ old\\ woman\\ with\\ a\\ history\\ of\\ relapsing\\ \\-\\ remitting\\ ms\\,\\ treated\\ with\\ immunomodulation\\ therapy\\.\\ she\\ presents\\ now\\ with\\ a\\ new\\ onset\\ of\\ numbness\\ in\\ both\\ lower\\ extremities\\.\ \(0\)\
\-\ active\\ ms\\ lesions\\ demonstrate\\ enhancement\\ following\\ gadolinium\\-\\ based\\ contrast\\ administration\\.\ \(0\)\
\-\ this\\ is\\ due\\ to\\ the\\ breakdown\\ of\\ the\\ brain\\ blood\\ barrier\\ from\\ inflammatory\\ inflitration\\ combined\\ with\\ features\\ of\\ myelin\\ destruction\\.\\ apart\\ from\\ this\\ easily\\ identifiable\\ finding\\ in\\ conventional\\ mri\\,\\ it\\ is\\ important\\ to\\ remember\\ that\\ normal\\-appearing\\ white\\ matter\\ outside\\ the\\ plaques\\ also\\ frequently\\ demonstrates\\ immunopathologic\\ changes\\ including\\ microglial\\ activation\\,\\ t\\-cell\\ infiltration\\,\\ and\\ perivascular\\ lymphocytic\\ cuffing\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ new\\:\\ 0\\.24224245625608903\ \(0\)\
\-\ active\\:\\ 0\\.2080137049702671\ \(0\)\
\-\ ms\\:\\ 0\\.20400233625222872\ \(0\)\
\-\ lesions\\:\\ 0\\.20109769089417487\ \(0\)\
\-\ the\\:\\ 0\\.19563181913155245\ \(0\)\
\-\ lhermitte\\:\\ 0\\.1799954277716521\ \(0\)\
\-\ spine\\:\\ 0\\.13878693148157997\ \(0\)\
\-\ sensation\\:\\ 0\\.12002739050209045\ \(0\)\
\-\ gadolinium\\:\\ 0\\.11670429395781098\ \(0\)\
\-\ susac\\:\\ 0\\.11199464902090919\ \(0\)\
\-\ immunomodulation\\:\\ 0\\.11199464902090919\ \(0\)\
\-\ immunopathologic\\:\\ 0\\.11199464902090919\ \(0\)\
\-\ microglial\\:\\ 0\\.11199464902090919\ \(0\)\
\-\ administration\\:\\ 0\\.11153813769649706\ \(0\)\
\-\ mri\\:\\ 0\\.10784294499969467\ \(0\)\
\-\ inflitration\\:\\ 0\\.10701686610095212\ \(0\)\
\-\ matter\\:\\ 0\\.10664534503252544\ \(0\)\
\-\ electric\\:\\ 0\\.10348507291334616\ \(0\)\
\-\ flexing\\:\\ 0\\.10348507291334616\ \(0\)\
\-\ remitting\\:\\ 0\\.10348507291334616\ \(0\)\
\-\ based\\:\\ 0\\.10145697850601468\ \(0\)\
\-\ vividly\\:\\ 0\\.10074560128873938\ \(0\)\
\-\ sclerosis\\:\\ 0\\.09976296572701655\ \(0\)\
\-\ juxtacortical\\:\\ 0\\.09850728999338909\ \(0\)\
\-\ sign\\:\\ 0\\.09696644067181279\ \(0\)\
\-\ relapsing\\:\\ 0\\.09661482475828136\ \(0\)\
\-\ of\\:\\ 0\\.0959331550980051\ \(0\)\
\-\ is\\:\\ 0\\.09589218376790276\ \(0\)\
\-\ activation\\:\\ 0\\.09497549680578313\ \(0\)\
\-\ cuffing\\:\\ 0\\.09352950707343201\ \(0\)\
\-\ white\\:\\ 0\\.09240880262910184\ \(0\)\
\-\ myelin\\:\\ 0\\.09223602518117635\ \(0\)\
\-\ any\\:\\ 0\\.0905191438229126\ \(0\)\
\-\ clinical\\:\\ 0\\.0887645799737675\ \(0\)\
\-\ apart\\:\\ 0\\.08810524865071832\ \(0\)\
\-\ brain\\:\\ 0\\.08731415166102113\ \(0\)\
\-\ breakdown\\:\\ 0\\.08725824226121927\ \(0\)\
\-\ in\\:\\ 0\\.08710707109540587\ \(0\)\
\-\ barrier\\:\\ 0\\.08435616265341304\ \(0\)\
\-\ from\\:\\ 0\\.08343990907593705\ \(0\)\
\-\ perivascular\\:\\ 0\\.08312746573076124\ \(0\)\
\-\ scan\\:\\ 0\\.08309710660713608\ \(0\)\
\-\ identifiable\\:\\ 0\\.08255635237320513\ \(0\)\
\-\ remember\\:\\ 0\\.08255635237320513\ \(0\)\
\-\ therapy\\:\\ 0\\.08047458387868217\ \(0\)\
\-\ multiplanar\\:\\ 0\\.07959567254315529\ \(0\)\
\-\ tumefactive\\:\\ 0\\.07959567254315529\ \(0\)\
\-\ lymphocytic\\:\\ 0\\.07874866615365624\ \(0\)\
\-\ trunk\\:\\ 0\\.07795634459065706\ \(0\)\
\-\ radiates\\:\\ 0\\.0772120728864536\ \(0\)\
\-\ demyelinating\\:\\ 0\\.0768562009185485\ \(0\)\
\-\ moving\\:\\ 0\\.07617398523485228\ \(0\)\
\-\ adem\\:\\ 0\\.07521687296605027\ \(0\)\
\-\ imaging\\:\\ 0\\.07360721206856635\ \(0\)\
\-\ or\\:\\ 0\\.07308750552137465\ \(0\)\
\-\ this\\:\\ 0\\.0721916314085065\ \(0\)\
\-\ conventional\\:\\ 0\\.07153257193834887\ \(0\)\
\-\ arms\\:\\ 0\\.07065529001377631\ \(0\)\
\-\ plaques\\:\\ 0\\.07065529001377631\ \(0\)\
\-\ demonstrates\\:\\ 0\\.07036552160017073\ \(0\)\
\-\ easily\\:\\ 0\\.07003616438051509\ \(0\)\
\-\ combined\\:\\ 0\\.06944676848309402\ \(0\)\
\-\ infiltration\\:\\ 0\\.06906899334568502\ \(0\)\
\-\ legs\\:\\ 0\\.06888437748700638\ \(0\)\
\-\ with\\:\\ 0\\.06856462509665467\ \(0\)\
\-\ multiple\\:\\ 0\\.06850727110846691\ \(0\)\
\-\ patient\\:\\ 0\\.06833260484822068\ \(0\)\
\-\ contrast\\:\\ 0\\.06805316536315342\ \(0\)\
\-\ occasionally\\:\\ 0\\.0671765281105773\ \(0\)\
\-\ differentiated\\:\\ 0\\.06686172308646852\ \(0\)\
\-\ indicating\\:\\ 0\\.0662553418987102\ \(0\)\
\-\ sensory\\:\\ 0\\.06596302515428377\ \(0\)\
\-\ also\\:\\ 0\\.06588105320448219\ \(0\)\
\-\ sarcoid\\:\\ 0\\.06567750709381924\ \(0\)\
\-\ vasculitis\\:\\ 0\\.0649914781710023\ \(0\)\
\-\ different\\:\\ 0\\.06409121042572795\ \(0\)\
\-\ destruction\\:\\ 0\\.06384566777574571\ \(0\)\
\-\ enhance\\:\\ 0\\.06268662620733217\ \(0\)\
\-\ numbness\\:\\ 0\\.06225200654639552\ \(0\)\
\-\ that\\:\\ 0\\.06078156548932503\ \(0\)\
\-\ light\\:\\ 0\\.06065277680020486\ \(0\)\
\-\ deficits\\:\\ 0\\.060192920671327525\ \(0\)\
\-\ must\\:\\ 0\\.060013695251045225\ \(0\)\
\-\ important\\:\\ 0\\.059321865844656894\ \(0\)\
\-\ and\\:\\ 0\\.05788410937557123\ \(0\)\
\-\ frequently\\:\\ 0\\.05767203149592442\ \(0\)\
\-\ good\\:\\ 0\\.05695806735878084\ \(0\)\
\-\ down\\:\\ 0\\.056888902537810336\ \(0\)\
\-\ compared\\:\\ 0\\.056616075237747594\ \(0\)\
\-\ features\\:\\ 0\\.05634917943834399\ \(0\)\
\-\ outside\\:\\ 0\\.05621787633377415\ \(0\)\
\-\ condition\\:\\ 0\\.05595940945557391\ \(0\)\
\-\ stage\\:\\ 0\\.05576906884824853\ \(0\)\
\-\ motor\\:\\ 0\\.055706272172964415\ \(0\)\
\-\ occurs\\:\\ 0\\.05521513775137044\ \(0\)\
\-\ placed\\:\\ 0\\.05457038837881501\ \(0\)\
\-\ includes\\:\\ 0\\.054456714203236264\ \(0\)\
\-\ reveals\\:\\ 0\\.053271197710241434\ \(0\)\
\-\ extremities\\:\\ 0\\.05321993783096714\ \(0\)\
\-\ previous\\:\\ 0\\.0529167934598646\ \(0\)\
\-\ ago\\:\\ 0\\.05124009341381707\ \(0\)\
\-\ presence\\:\\ 0\\.050317858223160906\ \(0\)\
\-\ including\\:\\ 0\\.05011758097162617\ \(0\)\
\-\ underwent\\:\\ 0\\.048242154911010054\ \(0\)\
\-\ now\\:\\ 0\\.048072818112487085\ \(0\)\
\-\ neoplasm\\:\\ 0\\.047806645664677516\ \(0\)\
\-\ inflammatory\\:\\ 0\\.04735429416350764\ \(0\)\
\-\ three\\:\\ 0\\.047010210607503336\ \(0\)\
\-\ positive\\:\\ 0\\.04614676401032422\ \(0\)\
\-\ finding\\:\\ 0\\.04603229489896242\ \(0\)\
\-\ revealed\\:\\ 0\\.045918883254086384\ \(0\)\
\-\ often\\:\\ 0\\.04569515545432961\ \(0\)\
\-\ differential\\:\\ 0\\.04550268328640327\ \(0\)\
\-\ mr\\:\\ 0\\.04531318214184621\ \(0\)\
\-\ frontal\\:\\ 0\\.045073758498930874\ \(0\)\
\-\ onset\\:\\ 0\\.04496882860160433\ \(0\)\
\-\ examination\\:\\ 0\\.04481309640869968\ \(0\)\
\-\ treated\\:\\ 0\\.04361021805129554\ \(0\)\
\-\ neck\\:\\ 0\\.04283983880557714\ \(0\)\
\-\ changes\\:\\ 0\\.042323753434595573\ \(0\)\
\-\ when\\:\\ 0\\.042302713629530836\ \(0\)\
\-\ syndrome\\:\\ 0\\.042218913145444306\ \(0\)\
\-\ following\\:\\ 0\\.04201188086559461\ \(0\)\
\-\ she\\:\\ 0\\.041687724126327416\ \(0\)\
\-\ two\\:\\ 0\\.041588155670975305\ \(0\)\
\-\ performed\\:\\ 0\\.041430506978188876\ \(0\)\
\-\ months\\:\\ 0\\.040763647460063716\ \(0\)\
\-\ blood\\:\\ 0\\.04067127137899549\ \(0\)\
\-\ lobe\\:\\ 0\\.04047045804551676\ \(0\)\
\-\ significant\\:\\ 0\\.04043429683159467\ \(0\)\
\-\ enhancement\\:\\ 0\\.040308564843444736\ \(0\)\
\-\ due\\:\\ 0\\.040255071411312376\ \(0\)\
\-\ these\\:\\ 0\\.03954643608409226\ \(0\)\
\-\ both\\:\\ 0\\.039052667525811144\ \(0\)\
\-\ physical\\:\\ 0\\.0379723596218132\ \(0\)\
\-\ into\\:\\ 0\\.037227218922865055\ \(0\)\
\-\ without\\:\\ 0\\.036938664857910794\ \(0\)\
\-\ woman\\:\\ 0\\.03647231978984706\ \(0\)\
\-\ demonstrate\\:\\ 0\\.03640712195604881\ \(0\)\
\-\ diagnosis\\:\\ 0\\.03630352030113665\ \(0\)\
\-\ it\\:\\ 0\\.03584783702531624\ \(0\)\
\-\ lower\\:\\ 0\\.03578586454010665\ \(0\)\
\-\ to\\:\\ 0\\.03501517304738265\ \(0\)\
\-\ have\\:\\ 0\\.03498427402744071\ \(0\)\
\-\ findings\\:\\ 0\\.03456305629909617\ \(0\)\
\-\ after\\:\\ 0\\.033973135826371806\ \(0\)\
\-\ presents\\:\\ 0\\.03368847599080491\ \(0\)\
\-\ which\\:\\ 0\\.03184374534123233\ \(0\)\
\-\ disease\\:\\ 0\\.029396482417459974\ \(0\)\
\-\ be\\:\\ 0\\.028408734963010062\ \(0\)\
\-\ not\\:\\ 0\\.027646532015375733\ \(0\)\
\-\ an\\:\\ 0\\.026779579686070087\ \(0\)\
\-\ history\\:\\ 0\\.026755856541972305\ \(0\)\
\-\ left\\:\\ 0\\.023889066116275857\ \(0\)\
\-\ on\\:\\ 0\\.02115053275627654\ \(0\)\
\-\ old\\:\\ 0\\.020726328567857694\ \(0\)\
